HeimDGX • NYSE
add
Quest Diagnostics Inc
Við síðustu lokun
201,58 $
Dagbil
198,87 $ - 203,15 $
Árabil
157,20 $ - 213,50 $
Markaðsvirði
21,98 ma. USD
Meðalmagn
1,03 m.
V/H-hlutf.
22,79
A/V-hlutfall
1,73%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 2,81 ma. | 7,06% |
Rekstrarkostnaður | 523,00 m. | 5,44% |
Nettótekjur | 245,00 m. | 10,36% |
Hagnaðarhlutfall | 8,73 | 3,07% |
Hagnaður á hvern hlut | 2,42 | 8,52% |
EBITDA | 537,00 m. | 5,92% |
Virkt skatthlutfall | 24,04% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 420,00 m. | -23,50% |
Heildareignir | 16,22 ma. | 0,45% |
Heildarskuldir | 8,94 ma. | -3,44% |
Eigið fé alls | 7,29 ma. | — |
Útistandandi hlutabréf | 109,87 m. | — |
Eiginfjárgengi | 3,09 | — |
Arðsemi eigna | 6,05% | — |
Ávöxtun eigin fjár | 7,09% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 245,00 m. | 10,36% |
Handbært fé frá rekstri | 465,00 m. | 0,22% |
Reiðufé frá fjárfestingum | -191,00 m. | 61,95% |
Reiðufé frá fjármögnun | -287,00 m. | -68,82% |
Breyting á handbæru fé | -12,00 m. | 94,42% |
Frjálst peningaflæði | 169,12 m. | 4,72% |
Um
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
Framkvæmdastjóri
Stofnsett
1967
Vefsvæði
Starfsfólk
51.500
